Introduction. Organ-graft recipients are at increased risk for developing c
utaneous tumors, mostly carcinomas; however, melanocytic nevi (MN) also dev
elop in excess numbers in these patients. The aim of this study was to asse
ss whether MN developing in pediatric organ graft recipients (OCR-MN) have
a higher proliferative profile than similar lesions developing in non-immun
osuppressed subjects (C-MN), a fact that could confer to them potential for
malignant transformation into melanoma.
Material and methods. The immunohistochemical expression of two proliferati
on-associated markers (MIB1/Ki67 and PCNA) and of p53 oncoprotein was compa
ratively studied in a group of 10 and OGR-MN and 12 C-MN.
Results. MIB1/Ki67 and p53 were very weakly, if at all, expressed in all tu
mors, whereas PCNA was expressed in the majority of tumor cells in both gro
ups of lesions. Overall, no significant differences were found between the
two groups studied.
Discussion. Melanocytic nevi developing in organ transplant children do not
have a higher proliferative potential, and therefore do not seem to be int
rinsically more prone to malignant transformation than similar lesions appe
aring in non-immunosuppressed children; however the possibility exists that
the decreased immune defense mechanisms indirectly favors the growth of th
ese lesions.